Ameritas Advisory Services’s Boston Scientific BSX Stock Holding History

Ameritas Advisory Services’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$517K	Buy	8,239 +970	+13%	+$77.6K	0.02%	566
2025 Q4	$693K	Buy	7,269 +5,273	+264%	+$517K	0.03%	456
2025 Q3	$195K	Sell	1,996 -455	-19%	-$47.1K	0.01%	623
2025 Q2	$263K	Sell	2,451 -700	-22%	-$70.8K	0.01%	661
2025 Q1	$294K	Sell	3,151 -4,214	-57%	-$424K	0.01%	711
2024 Q4	$658K	Buy	+7,365	New	+$648K	0.02%	510
2024 Q3	–	Sell	-7,343	Closed	-$565K	–	856
2024 Q2	$565K	Buy	7,343 +22	+0.3%	+$1.61K	0.02%	556
2024 Q1	$509K	Buy	+7,321	New	+$471K	0.02%	550
2023 Q4	–	Sell	-5,127	Closed	-$271K	–	694
2023 Q3	$271K	Buy	+5,127	New	+$269K	0.01%	658
2023 Q2	–	Sell	-6,657	Closed	-$340K	–	805
2023 Q1	$340K	Buy	6,657 +524	+9%	+$24.7K	0.02%	605
2022 Q4	$284K	Sell	6,133 -49	-0.8%	-$2.12K	0.01%	732
2022 Q3	$239K	Buy	6,182 +11	+0.2%	+$441	0.01%	657
2022 Q2	$230K	Buy	6,171 +782	+15%	+$31.8K	0.01%	709
2022 Q1	$239K	Hold	5,389	–	–	0.01%	735
2021 Q4	$229K	Buy	+5,389	New	+$226K	0.01%	737

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameritas Advisory Services's BSX Position: Q1 2026 in Review

Ameritas Advisory Services increased its Boston Scientific (BSX) stake by 13% in Q1 2026, buying an estimated $77.6K and bringing the position to 8,239 shares worth $517K. The position accounts for 0.02% of the portfolio, ranked #566.

Ameritas Advisory Services first reported a position in BSX in Q4 2021 and has held it in 15 quarters since. The position peaked at $693K in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Ameritas Advisory Services held 8,239 shares of Boston Scientific worth $517K as of Q1 2026.
Ameritas Advisory Services bought 970 Boston Scientific shares in Q1 2026, an estimated $77.6K.
Boston Scientific made up 0.02% of Ameritas Advisory Services's portfolio in Q1 2026, its #566 holding.
Ameritas Advisory Services first reported a position in Boston Scientific in Q4 2021 and has held it in 15 quarters since.
Ameritas Advisory Services's Boston Scientific position peaked at $693K in Q4 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Ameritas Advisory Services's 13F filing for Q1 2026, filed 12 May 2026.